Holen Sie sich die Stockscreener-App
5.53
0.54%
-0.03
Schlusskurs vom Vortag:
$5.56
Offen:
$5.54
24-Stunden-Volumen:
149.70K
Relative Volume:
0.28
Marktkapitalisierung:
$1.72B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-2.9892
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
+19.18%
1M Leistung:
+0.91%
6M Leistung:
-46.67%
1J Leistung:
-51.87%
1-Tages-Spanne:
$5.46
$5.62
1-Wochen-Bereich:
$4.5507
$5.67
52-Wochen-Spanne:
$4.32
$13.70
Alvotech Stock (ALVO) Company Profile
Vergleichen Sie ALVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.53 | 1.73B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-02-14 | Eingeleitet | UBS | Buy |
| 2024-01-29 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Herabstufung | Citigroup | Buy → Sell |
| 2022-07-26 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alvotech Aktie (ALVO) Neueste Nachrichten
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bakersfield.com
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Alvotech (NASDAQ:ALVO) Shares Gap DownHere's Why - MarketBeat
Alvotech (ALVO) Receives Underweight Rating from Barclays | ALVO Stock News - GuruFocus
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - The Malaysian Reserve
Alvotech initiated with an Underweight at Barclays - TipRanks
Barclays Downgrades Alvotech(ALVO.US) to Sell Rating, Cuts Target Price to $5 - 富途牛牛
Certain Ordinary Shares of Alvotech are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Certain Swedish Depository Receipts of Alvotech are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
What analysts say about Alvotech Z45 stockVolume Profile Analysis & Free Discover Dynamic Stocks - earlytimes.in
With Alvotech Stock Surging, Have You Considered The Downside? - Trefis
Alvotech Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Retail Surge: What technical signals suggest for BRT Apartments Corp stockTrade Risk Report & High Return Stock Watch Alerts - BỘ NỘI VỤ
Alvotech (NASDAQ:ALVO) Stock Price Up 6.3%Here's What Happened - MarketBeat
Alvotech (NasdaqGM:ALVO): Assessing Valuation After European Approval of Denosumab Biosimilar AVT03 - simplywall.st
How Alvotech Z45 stock correlates with oil marketsQuarterly Investment Review & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Alvotech (ICSE:ALVO) Price Target Decreased by 17.29% to 1,165.86 - Nasdaq
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - marketscreener.com
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Alvotech (ALVO) - ACCESS Newswire
Oaktree Capital Management LP Trims Position in Alvotech $ALVO - MarketBeat
Does Alvotech (Z45) stock trade below intrinsic valueQuarterly Portfolio Review & Entry Point Confirmation Signals - Newser
How Investors Are Reacting To Alvotech (ALVO) EU Approval Of AVT03 Denosumab Biosimilar - simplywall.st
Will Alvotech (Z45) stock hit analyst forecasts2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Alvotech Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Why Alvotech (Z45) stock remains stableWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Alvotech (ALVO): A Bull Case Theory - Finviz
Will Alvotech (Z45) stock beat Nasdaq index returnsJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Is Alvotech Equity Warrant stock a safe haven assetJuly 2025 Earnings & Reliable Volume Spike Alerts - Newser
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO - The AI Journal
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud Violations - ACCESS Newswire
What momentum indicators show for Alvotech stockWeekly Trade Analysis & Verified Momentum Stock Alerts - Newser
Alvotech (NASDAQ:ALVO) Reaches New 12-Month LowWhat's Next? - MarketBeat
Morgan Stanley Maintains Alvotech(ALVO.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
What technical patterns form on Alvotech (Z45) stock chartsPortfolio Return Report & Smart Money Movement Alerts - Newser
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman - Lelezard
Will Alvotech (Z45) stock rise with strong economyJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Defic - GuruFocus
Alvotech stock hits 52-week low at 4.69 USD By Investing.com - Investing.com Nigeria
Alvotech stock hits 52-week low at 4.69 USD - Investing.com
Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar - MSN
How Alvotech (Z45) stock trades under stagflation2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Why Alvotech (Z45) stock appeals to dividend investors2025 Price Momentum & Short-Term Swing Trade Alerts - Newser
European Commission Approves Denosumab Biosimilars for Alvotech, STADA, Dr. Reddy’s & Teva - Pearce IP
The SPC "Waiver Regulation" means what it says: Regeneron v Alvotech - Mishcon de Reya LLP
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Sto - The National Law Review
What analysts say about Alvotech Equity Warrant stockMarket Correction Analysis & Affordable Portfolio Strategies - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Sha - The National Law Review
Alvotech Hit By FDA Setback On Key Arthritis Drug - Finimize
Will Alvotech stock gain from strong economyDay Trade & Safe Capital Allocation Plans - BỘ NỘI VỤ
Who’s Hired? Alvotech Promotes McClellan To COO - Citeline News & Insights
Finanzdaten der Alvotech-Aktie (ALVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.87%
4.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):